Gilead hopes to evoke new autoimmune treatments with $659M deal – Fierce Biotech
The company has flagged multiple sclerosis, rheumatoid arthritis, Graves' disease, type 1 diabetes and celiac disease as focus areas. Gilead, ... The company has flagged multiple sclerosis, rheumatoid arthritis, Graves'…